Delivery Order SPE2DS23D0001-SPE2D626F9929

The U.S. Defense Department's Medical Supply Chain division awarded a $9,751.48 firm fixed-price delivery order to Meditrade Medical Trading GMBH, a Germany-based medical supplier, on November 6, 2025. The delivery order, designated as SARS-CoV-2 Flu RSV 10S, procures diagnostic test kits for infectious diseases including SARS-CoV-2, influenza, and respiratory syncytial virus to support U.S. military healthcare operations. The award carries no set-aside designation, reflecting the contractor's ability to compete effectively in the open federal marketplace. Performance will be completed in Germany by November 10, 2025, with the work supporting U.S. defense healthcare delivery, particularly for military personnel stationed in European locations.

This delivery order is issued under one of two single-award Blanket Purchase Agreements that Meditrade holds with the U.S. Army Medical Command, each valued at $2 million with completion through June 29, 2026. These BPAs enable the Army Medical Command to efficiently procure medical commodities and diagnostic equipment without individual competitive procurements. Meditrade has maintained an active federal contractor registration since 2004 and has demonstrated sustained capability as a primary supplier of medical resources to U.S. defense healthcare systems, including through a prior $2.88 million indefinite delivery contract with the Defense Logistics Agency. The company's portfolio encompasses diagnostic test kits, laboratory reagents, medical panels, and specialized medical equipment necessary to support pandemic response efforts and routine military medical operations.